Novák Z, Yáñez A, Kiss I, Kuna P, Tortajada-Girbés M, Valiente R; “Bilastine Paediatric Safety Study Group”.
Bilastine 10 mg had a safety and tolerability profile similar to that of placebo in children aged 2 to <12 years with allergic rhinoconjunctivitis or chronic urticaria.
